ARCHIVES

No Difference in Toxicity Between IMRT and PRT In Medicare Patients

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

SBIR Priority Score Median Must Match R01s Under House Bill

June 28, 1996

FDA Grants Orphan Designation To Photofrin for Mesothelioma

December 30, 2011

Petition Filed To Revoke NlH License To Use Radioactive Materials

October 20, 1995

Advocacy Groups Form Council To Lobby For Cancer Programs To Benefit Minorities

April 28, 1995

Research Base Would Be Increased In Guideline Change

November 9, 1990

New Cancer Survival, Incidence, Mortality Statistics Cause for Optimism, Concern

February 12, 1988